Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor During Oral Presentation at 2023 American Society of Hematology (ASH) Annual Meeting
Data on RPT1G, a clinical drug candidate for the treatment of solid and hematological malignancies, that selectively kills cancer cells and is thousands-fold better tolerated by healthy cells than previous NAMPT inhibitors.First presentation showcasing Remedy Plan’s unique, first-in-class mech
Government of Canada announces new economic incentive to reduce methane emissions from beef cattle
GATINEAU, QC, Dec. 10, 2023 /CNW/ – Against the backdrop of Food and Agriculture Day at COP28, the global community is witnessing a pivotal moment in the collective effort to address environmental challenges within the agricultural sector. As world leaders convene to deliberate on sustainable
At COP28, momentum increases for the Global Carbon Pricing Challenge
DUBAI, United Arab Emirates, Dec. 10, 2023 /CNW/ – Carbon pricing is most effective when more countries adopt it—broader coverage means more opportunities to find clean solutions. Through international cooperation, countries can send consistent signals that it cannot be free to pollute. Toda
/R E P E A T — NOTICE TO THE MEDIA – Government of Canada to make an announcement on oral health care for Canadians/
OTTAWA, ON, Dec. 8, 2023 /CNW/ – The Honourable Mark Holland, Minister of Health, the Honourable Terry Beech, Minister of Citizens’ Services, the Honourable Jean-Yves Duclos, Minister of Public Services and Procurement Canada, and the Honourable Seamus O’Regan Jr., Minister of Labo
The Cigna Group Announces Significant Increase to Share Repurchase Program of $10 Billion
Intends to Repurchase at Least $5 Billion of Common Stock by End of First Half of 2024, with Portion Executed Via ASR in First Quarter 2024 Reaffirms Previously Provided Outlook for Full-Year 2023 BLOOMFIELD, Conn., Dec. 10, 2023 /PRNewswire/ — Global health company The Cigna Group (NYSE: CI
Applicants Wanted: The Fighting and Managing Wildfire in a Changing Climate Program – Training Fund
OTTAWA, ON, Dec. 10, 2023 /CNW/ – As climate change continues to impact the frequency, intensity and severity of wildfires in many provinces and territories, the Government of Canada is continuing to support Canadians now while strengthening Canada’s preparedness for years to come. Inves
Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
82% ORR and deep clinical responses from off-the-shelf, allogeneic BCMA-targeted CAR-T in heavily pretreated patients receiving adequate lymphodepletion 100% ORR in these patients who were not previously treated with a BCMA-targeted bispecific T cell-engaging antibody Favorable emerging safety and r
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Multiplex allogeneic epigenetic edits demonstrate elimination of graft-versus-host disease and resistance of CD8+T, CD4+T, and NK cell responses, while preserving genomic integrity Chroma’s allogeneic approach has the potential to drive greater persistence of a CAR T relative to current allog
Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches
 Findings suggest “less is more” and “tried and true” may benefit select patients SAN DIEGO, Dec. 10, 2023 /PRNewswire/ — Research findings being presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition highlight new treatment approaches
Aqua Bridge Group and Enertech launch Aqua Bridge Kuwait at COP28, in boost for local food systems and fisheries
Joint venture poised to decarbonize Kuwait’s food supply chains, reinforce resource resilience of aquaculture and fisheries sectors DUBAI, UAE, Dec. 10, 2023 /PRNewswire/ — Aqua Bridge Group, a global leader in aquaculture development, and Enertech, the Kuwait-based innovator, investor
